Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior ...
Neoadjuvant PD-1/PD-L1 inhibitors combined with chemotherapy in early-stage triple-negative breast cancer: A systematic review and meta-analysis.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果